SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-07-000182
Filing Date
2007-03-09
Accepted
2007-03-09 16:38:02
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a28112e10vk.htm 10-K 764918
2 EXHIBIT 23.1 a28112exv23w1.htm EX-23.1 2365
3 EXHIBIT 23.2 a28112exv23w2.htm EX-23.2 2152
4 EXHIBIT 31.1 a28112exv31w1.htm EX-31.1 8576
5 EXHIBIT 31.2 a28112exv31w2.htm EX-31.2 8592
6 EXHIBIT 32.1 a28112exv32w1.htm EX-32.1 3260
7 EXHIBIT 32.2 a28112exv32w2.htm EX-32.2 3252
8 GRAPHIC a28112a2811201.gif GRAPHIC 10632
  Complete submission text file 0000936392-07-000182.txt   809355
Mailing Address
Business Address 11588 SORRENTO VALLEY ROAD SUITE 17 SAN DIEGO CA 92121 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32335 | Film No.: 07684949
SIC: 2836 Biological Products, (No Diagnostic Substances)